Human papillomavirus DNA as a factor determining the survival of bladder cancer patients
1996

HPV DNA and Bladder Cancer Survival

Sample size: 76 publication Evidence: moderate

Author Information

Author(s): A Lopez-Beltran, AL Escudero, L Vicioso, E Muñoz, J Carlos Carrasco

Primary Institution: Reina Sofia University Hospital, Cordoba University Medical School

Hypothesis

Does the presence of human papillomavirus (HPV) DNA in transitional cell carcinoma (TCC) specimens correlate with patient survival?

Conclusion

The presence of HPV 16 DNA is associated with reduced survival in bladder cancer patients, but pathological grade remains the only independent prognostic factor.

Supporting Evidence

  • 7 out of 76 cases were reactive for HPV 16 DNA.
  • Pathological grade was the only independent factor in bladder cancer survival.
  • 16 out of 76 cases had koilocytosis, which was significant for survival.

Takeaway

This study found that some bladder cancer patients have a virus called HPV, which can make their cancer worse. Knowing if someone has this virus can help doctors understand how serious their cancer might be.

Methodology

The study analyzed 76 TCC specimens for HPV DNA using PCR and correlated findings with patient survival, considering other clinical variables.

Limitations

The study was limited to a specific population and may not generalize to all bladder cancer patients.

Participant Demographics

Mean age was 66.57 years, with 14 female participants.

Statistical Information

P-Value

P = 0.0418

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication